Aurelio Sessa

Dr. Aurelio Sessa

orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2013 in Antibiotics
Verified
Journal Article
Open access
PDF file
AVAlike Van Der Velden
Alike Van Der Velden
MDMartin G. Duerden
Martin G. Duerden
JBJohn Bell
John Bell
JOJohn S. Oxford
John S. Oxford
AAAttila Altiner
Attila Altiner
SESabiha Yusuf Essack
Sabiha Yusuf Essack
Inappropriate antibiotic use in normally self-limiting acute respiratory tract infections (RTIs), such as sore throat and the common cold, is a global problem and an important factor for increasing levels of antibiotic resistance. A new group of international experts—the Global Respiratory Infection Partnership (GRIP)—is committed to addressing this issue, with the interface between primary care practitioners and their patients as their core focus. To combat the overuse of antibiotics in the community, and facilitate a change from prescribing empiric antibiotic treatment towards cautious deferment combined with symptomatic relief, there is a need to introduce and enhance evidence-based dialogue between primary care practitioners and their patients. Communication with patients should focus on the de-medicalisation of self-limiting viral infections, which can be achieved via a coherent globally endorsed framework outlining the rationale for appropriate antibiotic use in acute RTIs in the context of antibiotic stewardship and conservancy. The planned framework is intended to be adaptable at a country level to reflect local behaviours, cultures and healthcare systems, and has the potential to serve as a model for change in other therapeutic areas.

28 October 2020 in Antibiotics
Verified
Journal Article
Open access
PDF file
SESabiha Yusuf Essack
Sabiha Yusuf Essack
JBJohn Bell
John Bell
DBDouglas Burgoyne
Douglas Burgoyne
WTWirat Tongrod
Wirat Tongrod
MDMartin Duerden
Martin Duerden
ASAdrian Shephard
Adrian Shephard
Pharyngitis (also known as sore throat) is a common, predominately viral, self-limiting condition which can be symptomatically managed without antibiotic treatment. Inappropriate antibiotic use for pharyngitis contributes to the development and spread of antibiotic resistance. However, a small proportion of sore throats caused by group A streptococcal (GAS) infection may benefit from the provision of antibiotics. Establishing the cause of infection is therefore an important step in effective antibiotic stewardship. Point-of-care (POC) tests, where results are available within minutes, can distinguish between viral and GAS pharyngitis and can therefore guide treatment in primary healthcare settings such as community pharmacies, which are often the first point of contact with the healthcare system. In this opinion article, the evidence for the use of POC testing in the community pharmacy has been discussed. Evidence suggests that pharmacy POC testing can promote appropriate antibiotic use and reduce the need for general practitioner consultations. Challenges to implementation include cost, training and ‘who prescribes’, with country and regional differences presenting a particular issue. Despite these challenges, POC testing for pharyngitis has become widely available in pharmacies in some countries and may represent a strategy to contain antibiotic resistance and contribute to antimicrobial stewardship.

1 June 2019 in Preventive Medicine Reports
Verified
Journal Article
Open access
ASAndrea Salvetti
Andrea Salvetti
VFVincenzo Ferrari
Vincenzo Ferrari
RGRemigio Garofalo
Remigio Garofalo
PGPietro Gazzaniga
Pietro Gazzaniga
AGAlessandro Guerroni
Alessandro Guerroni
BSBenedetto Simone
Benedetto Simone
Herpes zoster (HZ) mainly affects older adults and immunocompromised individuals and is usually characterized by a unilateral painful skin rash. Its most common complication, postherpetic neuralgia (PHN), may cause chronic debilitating pain lasting for months or years. This study (ClinicalTrials.gov Identifier: NCT01772160) aimed to estimate the HZ incidence and the proportion of HZ patients with PHN in the Italian population aged 50 years or older. From 2013 to 2016, HZ-patients were recruited when presenting with acute HZ at 75 reporting general practitioners in Italy, covering 43,875 persons aged ≥50 years. PHN was defined as 'worst pain' rated ≥ 3 on the Zoster Brief Pain Inventory persisting or appearing over 90 days after rash onset. The overall HZ incidence rate per 1000 person-years (PY) was estimated as 6.46 (95% confidence interval [CI]: 5.99-6.95), increasing with age to 9.12/1000 PY (95% CI: 7.50-10.99) in 75-79 year-olds. Among 391 HZ-patients who completed the study, the overall proportion with PHN was 10.23% (95% CI: 7.41-13.67) and the highest proportion was 15.56% (95% CI: 6.49-29.46) for the 75-79 year-olds. Among the 128 patients (32.7%) who reported at least one pre-existing medical condition, 35.9% reported diabetes mellitus and 32.0% reported emotional problems, stress or depression. The study confirms previous findings that HZ and PHN cause an important clinical burden in older Italian adults. It also confirmed the age-related increasing risk of HZ and PHN.

15 December 2018
Verified
Journal Article
Open access
PDF file
GIGiancarlo Icardi
Giancarlo Icardi
FFFausto Francia
Fausto Francia
PBPaolo Di Bartolo
Paolo Di Bartolo
DMDomenico Mannino
Domenico Mannino
EAElisabetta Alti
Elisabetta Alti
ASAurelio Sessa
Aurelio Sessa

19 April 2022 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
ASAurelio Sessa
Aurelio Sessa
MGMarco Gattamorta
Marco Gattamorta
MPMAURIZIA PUNGINELLI
MAURIZIA PUNGINELLI
GMGianluigi Maggioni
Gianluigi Maggioni
Spontaneous events have been reported after COVID-19 vaccination. In this case, we report a thrombotic event in an unusual site (ulnar artery) after COVID-19 vaccination. The patient (69 year-old-male) had no changes after a laboratory investigation regarding thrombophilic pattern, but nevertheless had atherothrombotic predisposing conditions. Arterial thrombotic events have more frequently been reported after mRNA vaccines than after adenovirus vaccines. This is the first case reported of thrombosis of the ulnar artery occurring in the same side of the body where the vaccination took place. However, it must be noted that COVID-19 vaccines cumulatively offer a net positive effect, despite rare adverse effects.

1 July 2014 in Giornale di Tecniche Nefrologiche e Dialitiche
Verified
Journal Article
Closed access
ASAurelio Sessa
Aurelio Sessa